For decades, governments measured progress by how efficiently they delivered services. Today, a more demanding benchmark is taking shape: how effectively public institutions anticipate, adapt, and ...
Like a lot of people, I keep saving 60-second coding tutorials from Instagram that are basically impossible to follow later — the code is on screen for two seconds, the narration skips half the steps, ...
Ras Al Khaimah Transport Authority (Rakta) has relaunched the Purple Route (Al Nakheel – Manar Mall), marking a major step in enhancing public transport services and advancing sustainable mobility ...
For Drew Rasmussen and the Rays, the issue lately has been falling behind. Looking back at a rare rough outing as he stood in the Rays’ dugout at Tropicana Field on Wednesday morning, Rasmussen put it ...
Free rides for a month as upgraded route adds 14km and improves city connectivity Ras Al Khaimah: Residents and visitors in Ras Al Khaimah can now experience the emirate's first electric public bus ...
Medtronic stated that expanding Hugo’s indicated use aims to meet growing demand in general and gynaecological minimally invasive surgery. Credit: Gorodenkoff / Shutterstock.com. Medtronic has ...
b RAS G12, G13 or Q61 mut or no RAS mut identified. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting II. This abstract does not include a full text component.
Tri-complex inhibitors (TCIs) are molecular glues that bind to active GTP-bound RAS and recruit the intracellular chaperone cyclophilin A (CYPA) to generate a synthetic inhibitory complex that blocks ...
An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...
The facility has been at the center of advocates protesting over claims that detainees are being housed in poor living conditions without adequate medical care. However, demonstrations have led to ...
CHICAGO — The American Society of Clinical Oncology’s annual meeting always features data with the potential to change clinical practice. This year’s meeting, though, was headlined by the kind of ...
At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results